Inhaled insulin is an “important alternative” to injected rapid-acting analog insulin for children and teens with diabetes, ...

The once-weekly insulin analog lowered A1c as effectively as once-daily formulations in three new trials in type 2 diabetes.

A study finds that inhaled insulin is as effective as traditional injections for children with type 1 diabetes during ...

Children with diabetes who inhaled their mealtime doses of insulin did just as well as those who injected insulin under the ...

Stay Informed On Tariff Changes, Macroeconomic Trends, And More.” — The Business Research Company LONDON, GREATER LONDON, UNITED KINGDOM, June 30, 2025 /EINPresswire.com/ -- How Big Is The Global ...

Children with diabetes who inhaled their mealtime doses of insulin did just as well as those who injected insulin under the ...

Today, a new study demonstrates inhaled insulin as a safe and effective replacement for rapid-acting meal insulin in children with type 1 diabetes. Results from the INHALE-1 study were presented today ...

The global Insulin Delivery Device Market, valued at US$32.6 billion in 2024 stood at US$35.3 billion in 2025 and is ...

Dr. Lily Ackermann discussed inpatient diabetes care, focusing on real-world decisions and personalized treatment using ...

Indian drugmakers Biocon, Eris Lifesciences, and Wockhardt are ramping up insulin production to capture a growing global opportunity, as market leader Novo Nordisk scales back its presence in ...

Novo Nordisk has developed a new version of the insulin analogue, called Fiasp, which added another DKK 1.6 billion to the fast-acting insulin pot last year and has patent protection to 2030.